Impact of N-acetyltransferase polymorphism (NAT2) in hepatocellular carcinoma (HCC) – an investigation in a department of surgical medicine

By Farker Katrin   Schotte Uwe   Scheele Johannes   Hoffmann Annemarie  

Experimental and Toxicologic Pathology, Vol. 54, Iss. 5-6, 2003-05 ,pp. : 387-391

Urban & Fischer

Access to resources Recommend Favorite

Polymorphism in the N-acetyltransferase 1 alleles NAT1*10 and NAT1*14A and cytological gradings of exfoliated urothelial cells in benzidine-exposed Chinese workers: discussion of ethnic differences

By Guo Wei Chao   Lin Guo Fang   Chen Ji Gang   Golka Klaus   Shen Jian Hua  

Archives of Toxicology, Vol. 78, Iss. 8, 2004-08 ,pp. : 425-429

Springer Publishing Company

Access to resources Recommend Favorite

Refinement of the prediction of N-acetyltransferase 2 (NAT2) phenotypes with respect to enzyme activity and urinary bladder cancer risk

By Selinski Silvia   Blaszkewicz Meinolf   Ickstadt Katja   Hengstler Jan   Golka Klaus  

Archives of Toxicology, Vol. 87, Iss. 12, 2013-12 ,pp. : 2129-2139

Springer Publishing Company

Access to resources Recommend Favorite

The influence of dose and N-acetyltransferase-2 (NAT2) genotype and phenotype on the pharmacokinetics and pharmacodynamics of isoniazid

By Donald P.   Parkin D.   Seifart H.   Schaaf H.   Helden P.   Werely C.   Sirgel F.   Venter A.   Maritz J.  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 7, 2007-07 ,pp. : 633-639

Springer Publishing Company

Access to resources Recommend Favorite

NAT2 sequence polymorphisms and acetylation profiles in Indians

By Khan Naazneen   Pande Veena   Das Aparup  

Pharmacogenomics, Vol. 14, Iss. 3, 2013-02 ,pp. : 289-303

Future Medicine

Access to resources Recommend Favorite